KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals (KaloBios) is a biotechnology company that uses its proprietary technologies and proven antibody development team to develop human antibody therapeutics. Products are being developed in three areas: Infectious Disease, autoimmunity, and oncology. KaloBios' pipeline is initially focused on clinically validated targets and the company is aggressively pursuing an in-licensing strategy for more advanced development candidates. To expand KaloBios' access to successful drug candidates, and to offer the rich capabilities of the KaloBios technology portfolio and team to other companies, KaloBios is offering access to its technologies through funded collaborations.

Contact Details: 3427 Hillview Avenue Palo Alto California 94304 United States of America Tel: 650.843.1897 Fax: 650.843.1896 Email: admin@kalobios.com WWW: www.kalobios.com/

Loading...

Press Releases on KaloBios Pharmaceuticals, Inc.:
BioWa Announces License of Biowa's Potelligent(R) Technology to KaloBios Pharmaceuticals	28th October, 2008		PRINCETON, New Jersey, October 28 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into an agreement with KaloBios Pharmaceuticals, Inc., under which BioWa licenses to KaloBios its

BioNews Results for KaloBios Pharmaceuticals, Inc.:
Medical News: KaloBios' KB001 Antibody Shows Encouraging Safety And Activity In New Approach To Fighting Pseudomonas Infection In Cystic Fibrosis Patients	Medical News Today:  Oct 18 2009 10:55AM Matching: kalobios pharmaceuticals inc
KaloBios' KB001 Antibody Shows Encouraging Safety And Activity In New Approach To Fighting Pseudomonas Infecti	Medical News Today:  Oct 18 2009 8:36AM Matching: kalobios pharmaceuticals inc
KaloBios' KB001 Antibody Shows Encouraging Safety and Activity in New Approach to Fighting ...	PipelineReview:  Oct 17 2009 6:33AM Matching: kalobios pharmaceuticals inc
KaloBios' KB001 Antibody Shows Encouraging Safety and Activity in New Approach to Fighting Pseudomonas Infecti	Pharma Live:  Oct 15 2009 9:57PM Matching: kalobios pharmaceuticals inc
KaloBios KB001 Antibody Shows Encouraging Safety and Activity in New Approach to Fighting Pseudomonas Infec	Genetic Engineering News:  Oct 15 2009 1:38PM Matching: kalobios pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more KaloBios Pharmaceuticals, Inc. news.

KaloBios Pharmaceuticals, Inc. Patents:
US Patent No.	Title
7432063	Methods for affinity maturation
7335478	Reactivation-based molecular interaction sensors

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 630 times since April 2007, the link to the organisation's website has been followed 95 times

Recent Search Terms used to find this page: kalobios collaborations | Kalobios Pharmaceuticals Inc | Kalobios Pharmaceuticals Inc | Kalobios Pharmaceuticals Inc. | Kalobios Pharmaceuticals | website for kalobios pharmaceuticals | Kalobios logo | KaloBios Pharmaceuticals Inc | KaloBios Pharmaceuticals Inc | Kalobios Pharmaceuticals 3 | .

Search for more companies in Palo Alto

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for KaloBios Pharmaceuticals, Inc.